CCND1 and gastric cancer: To examine whether ER-α36-mediated estrogen signaling induces cyclin D1 expression in gastric cancer cells, the cells were treated with E2β (0.1 nM) for 12 h and a western blot analysis was performed to examine cyclin D1 expression.